When combined with overweight/obesity, the risks of serious long-term complications and overall mortality associated with diabetes are further increased [3,4,5]
Or what things do they take into account
In clinical trials, tirzepatide has demonstrated a positive impact on lipid profiles, including reductions in total cholesterol and low-density lipoprotein cholesterol (LDL-C), often referred to as bad cholesterol
A new study by Zepbounds maker, Eli Lilly, examined data from nearly 5,000 people with obesity and obesity-related conditions in four different studies and found that the drugs weight-loss effects were stronger than those of a placebo
By activating these pathways in controlled experiments, researchers can observe changes in hormone secretion patterns and metabolic activity